Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 66 (ZNF66) is a member of the large zinc finger protein family, characterized by containing C2H2-type zinc finger domains that enable sequence-specific DNA binding. ZNF66 is believed to function primarily as a transcription factor, regulating gene expression in human cells[3][2][1]. While the specific biological roles and regulatory targets of ZNF66 have not been extensively characterized, zinc finger proteins as a class are involved in diverse cellular processes including transcriptional regulation, cell proliferation, differentiation, development, and apoptosis[2][1]. There are no direct data to suggest ZNF66 is a therapeutic target or linked to common diseases, although the general family participates in health and disease mechanisms such as tumorigenesis and neurodegeneration[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 66 (ZNF66).